Company Overview - Molina Healthcare, Inc. (MOH) is based in Long Beach, California, and provides managed healthcare services to low-income families and individuals under Medicaid and Medicare programs, as well as through state insurance marketplaces. The company has a market capitalization of $7.3 billion and operates health plans in California, Washington, Utah, and Michigan, along with primary care clinics in Northern and Southern California [1] Earnings Expectations - Analysts anticipate that MOH will report a profit of $1.68 per share on a diluted basis for the fiscal first quarter of 2026, representing a significant decline of 72.4% from $6.08 per share in the same quarter last year [2] - For the full fiscal year, the expected EPS is $5.03, down 54.4% from $11.03 in fiscal 2025, but is projected to rise by 65.2% year over year to $8.31 in fiscal 2027 [3] Earnings History - In the previous quarters, MOH's earnings have shown volatility, with reported EPS of $6.08, $5.48, $1.84, and a loss of $2.75 for the quarters ending in March, June, September, and December 2025, respectively. The company has missed consensus estimates in three of the last four quarters [4] Stock Performance - MOH stock has underperformed significantly, with a decline of 57.1% over the past 52 weeks, contrasting with the S&P 500 Index's gain of 13.4% during the same period [5] - Following the Q4 results reported on February 5, where adjusted losses of $2.75 missed expectations, the stock fell by 25.5% in the subsequent trading session [6] Analyst Ratings - The consensus opinion among analysts on MOH stock is cautious, with a "Hold" rating overall. Out of 18 analysts, 2 recommend a "Strong Buy," 13 suggest a "Hold," 1 advises a "Moderate Sell," and 2 advocate a "Strong Sell." The average analyst price target is $144.40, indicating a potential upside of 4% from current levels [7]

Core Insights - Molina Healthcare, Inc. (NYSE:MOH) is recognized as one of the best stocks to buy according to billionaire Seth Klarman, with a new addition of over 620,000 shares in the Baupost Group's 13F portfolio [1] - The company projected 2026 premium revenue to be approximately $42 billion, slightly lower than 2025, with Medicaid rates expected to average around 4%, not offsetting a projected medical cost trend of 5% [1] - CEO Joseph Zubretsky announced a Medicaid contract win in Florida, expected to yield $6 billion in annual run rate premium, going live in late 2026, and highlighted an active pipeline of $50 billion in new opportunities [3][4] Financial Projections - Management's guidance for 2026 includes a decline in Marketplace premium by 50% and a combined headwind of $1 per share from Medicare and Marketplace segments [1] - The company provides managed healthcare services to low-income families and individuals under Medicaid and Medicare programs, as well as through state insurance marketplaces in the U.S. [4]

分组1 - Seth Klarman of Baupost Group manages a 13F portfolio valued at over $5.2 billion, with top holdings in consumer cyclical, technology, and industrial sectors [1] - Klarman emphasizes the importance of a margin of safety in investments, which allows for room to be wrong, and stresses the need for differentiation to outperform the market [2][3] - The Baupost Group employs structural guardrails to avoid leveraging and diversify across countries and asset classes, enhancing downside protection [3] 分组2 - Molina Healthcare, Inc. (NYSE:MOH) is a new addition to Baupost Group's portfolio, with a stake of $108 million comprising over 620,000 shares [7] - Molina's management projects 2026 premium revenue to be approximately $42 billion, slightly lower than 2025, with Medicaid rates expected to average around 4% [7] - The company has secured a Medicaid contract in Florida, anticipated to generate $6 billion in annual run rate premium, and has an active pipeline of $50 billion in new opportunities [8][9]

Core Insights - Redwood Capital Management disclosed a purchase of 51,600 shares of Molina Healthcare, valued at approximately $8.48 million based on quarterly average pricing [1][2] - The total position in Molina Healthcare increased to 110,000 shares, with a quarter-end value of $19.09 million, reflecting a net position change of $7.91 million due to price appreciation [2] Company Overview - Molina Healthcare is a leading provider of managed healthcare services, focusing on government-sponsored programs such as Medicaid and Medicare [6] - The company generated $45.43 billion in revenue over the trailing twelve months (TTM) and reported a net income of $472 million [4] Financial Performance - Molina Healthcare's stock price was $148.79, down 53% over the past year, significantly underperforming the S&P 500, which increased by about 19% during the same period [8] - The company faced a decline in profitability, with adjusted EPS falling to just over $11 from $22.65 the previous year, as the fourth quarter resulted in a loss [10] Market Position and Strategy - Molina Healthcare serves approximately 5.1 million members through a scalable, capitated payment structure, primarily targeting low-income families and individuals [9] - The company is positioned defensively within Redwood Capital's portfolio, contrasting with higher-growth, higher-volatility investments [11] - Guidance for 2026 anticipates a 2% year-over-year decline in premium revenue to about $42 billion, with adjusted earnings per share projected to be at least $5 as the company navigates contract resets [11]

Core Viewpoint - Molina Healthcare, Inc. is experiencing significant stock price declines and underperformance compared to its peers, raising concerns among analysts regarding its future prospects [3][6][8]. Company Overview - Molina Healthcare, Inc. is based in Long Beach, California, and provides managed healthcare services to low-income families and individuals under Medicaid and Medicare programs, as well as through state insurance marketplaces in the U.S. The company has a market capitalization of $7.5 billion and operates through various segments including Medicaid, Medicare, Marketplace, and Other [1]. Stock Performance - The stock reached a 52-week high of $359.97 on April 4, 2025, but has since declined by 59.3% from that peak. Over the past three months, the stock has decreased by 8.9%, underperforming the State Street Healthcare Select Sector SPDR ETF (XLV), which declined by 1.8% during the same period [3][6]. - Over the past 52 weeks, Molina's shares have dropped by 52.5%, while XLV has increased by 2.9%, indicating a significant underperformance [6]. Earnings Report - On February 6, 2025, the stock fell by 25.5% following the release of Q4 2025 earnings. The company's revenue grew by 8.3% year-over-year to $11.4 billion, exceeding forecasts. However, the adjusted loss per share was $2.75, down from an EPS of $5.05 in the previous year, which did not meet Wall Street estimates. Additionally, the full-year revenue guidance was below analysts' expectations, further eroding investor confidence [7]. Peer Comparison - Compared to its peer, Centene Corporation (CNC), which has declined by 40.3% over the past 52 weeks, Molina Healthcare has shown weaker performance. Among 18 analysts covering Molina, the consensus rating is a "Hold." Although the stock trades at a premium to its mean price target of $144.40, the highest price target of $180 suggests a potential upside of 22.9% [8].

Group 1 - Molina Healthcare Inc. (NYSE:MOH) is considered one of the most undervalued mid-cap stocks currently available for investment [1] - Goldman Sachs lowered its price target for Molina Healthcare to $124 from $167 while maintaining a Neutral rating after the company's Q4 2025 earnings miss [1][4] - UBS analyst AJ Rice also reduced the price target for Molina Healthcare to $145 from $170, citing challenges in the Medicaid and exchanges backdrop while keeping a Neutral rating [3] Group 2 - The return profiles for strong operators in low-margin, government-priced cyclical businesses, such as managed care organizations, can diminish rapidly during economic downturns [2] - Goldman Sachs anticipates that challenges in the managed care sector will persist due to its sensitivity to the current cyclical environment [2]

Company Overview - Molina Healthcare (MOH) is a managed healthcare provider serving over 5.6 million members across Medicaid, Medicare, and Marketplace programs in 21 states, with Medicaid accounting for approximately 75% of premium revenue [15][16]. - The company is currently facing a challenging margin environment, marking the second consecutive year of industry-wide losses due to post-COVID redeterminations that removed around 17 million beneficiaries from Medicaid rolls [16]. Financial Performance - Despite industry headwinds, Molina continues to generate profit, with a medical loss ratio (MLR) approximately 250 basis points better than the industry average [18]. - Management expects Medicaid to generate roughly $16 per share of earnings in 2025, with a conservative estimate of approximately $14 of EPS from Medicaid for 2026 [18]. - Each 100 basis point improvement in Medicaid MLR translates to about $4.50 in incremental EPS for the company [19]. Growth Potential - Molina's management targets 11-13% annual premium growth, largely from strategic contract wins, with embedded earnings from recently awarded contracts amounting to roughly $8.65 per share [21]. - If Medicaid rates revert toward the high end of management's long-term MLR guidance, Molina could earn approximately $37 per share in 2028, assuming a 4.5% pretax margin [23]. - The company has repurchased $1 billion of stock year-to-date, including 5.3% of shares in the most recent quarter, and has plans for additional buybacks [24]. Valuation and Market Position - Molina's five-year average multiple is approximately 15x earnings, suggesting significant upside potential; applying a 13x multiple to $40 of 2028 EPS yields a share price of roughly $520, representing approximately 225% upside from current levels [25]. - Concerns regarding the long-term role of managed care organizations in Medicaid are viewed as overstated, as approximately 75% of Medicaid beneficiaries currently receive care through HMOs [22].

Company Overview - Molina Healthcare, Inc. is a leading provider of managed healthcare services focused on government-sponsored programs such as Medicaid and Medicare [6] - The company serves low-income families, individuals, and seniors eligible for Medicaid and Medicare in 18 U.S. states, with approximately 5.2 million members as of December 31, 2021 [7] - Revenue for the trailing twelve months (TTM) is $54.07 billion, with a net income of $883 million and a market capitalization of $7.50 billion [5] Recent Developments - Cobalt Capital Management disclosed a new position in Molina Healthcare, acquiring 115,000 shares valued at approximately $22.01 million, which represents 10.11% of the fund's reportable assets [2][3] - As of November 13, 2025, Molina Healthcare's stock price was $138.48, reflecting a decline of 55.23% over the past year, underperforming the S&P 500 by 69.17 percentage points [4] Investment Insights - Cobalt Capital's significant investment suggests a belief that the market has misjudged the company's potential, indicating a gap between the stock's decline and Molina's cash-generating capabilities [10] - The company's revenue model relies on government contracts that pay a fixed amount per member, making financial performance dependent on effective management of medical costs [11] - Recent challenges in rate negotiations and rising medical costs have negatively impacted the stock price, but the underlying business retains advantages that could support future growth [12]

Core Viewpoint - Molina Healthcare is facing significant operational and financial challenges, with declining Medicaid enrollment and increasing costs impacting profitability and outlook [2][3][6]. Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicare and Medicaid programs [1]. Financial Performance - The company has missed earnings estimates in three of the last four quarters, with a notable miss of -53.65% in Q3, resulting in a trailing four-quarter average earnings miss of -15.8% [6]. - Analysts have revised fourth-quarter earnings estimates down by -87.28% over the past 60 days, with the current Zacks Consensus EPS Estimate at 43 cents, reflecting a negative growth of -91.5% year-over-year [7][8]. Operational Challenges - Medicaid membership has declined by 5.2% in the first nine months of 2025, indicating difficulties in enrollment growth [2]. - Operating expenses have consistently increased, leading to pressure on margins and a worsening medical care ratio [3]. Industry Context - Molina Healthcare is ranked as a Zacks Rank 5 (Strong Sell) and is part of the bottom 16% of the Zacks Medical – HMOs industry group, which is expected to underperform the market in the next 3 to 6 months [4]. - The stock has been underperforming, hitting a 52-week low last month, and is considered a compelling short opportunity [5]. Technical Analysis - The stock is in a sustained downtrend, trading below both the 50-day and 200-day moving averages, indicating bearish sentiment [9][12]. - A "death cross" has occurred, suggesting that significant upward movement would be required to consider long positions [12]. Final Assessment - The combination of deteriorating fundamentals, negative earnings revisions, and inclusion in a poorly performing industry group suggests that Molina Healthcare is unlikely to see significant recovery in the near term [13][14].

Core Insights - Molina Healthcare stock (NYSE: MOH) has experienced a decline of approximately 27% over the past month due to significant negative developments following its Q3 2025 report, yet it remains a potential investment opportunity due to historical rebound patterns [2][5] Financial Performance - Q3 profitability has substantially decreased, leading to a cut in the full-year earnings forecast [5] - Revenue growth has been reported at 13.7% for the last twelve months (LTM) and an average of 12.8% over the last three years [6] - The minimum annual revenue growth in the last three years was 6.7% [6] - The stock trades at a price-to-earnings (PE) multiple of 8.4 [6] Operational Challenges - Rising medical costs within the Marketplace business segment are a concern [5] - The company faces external pressures from market anxiety regarding new regulatory proposals and several shareholder lawsuits [5] Market Position - The stock is currently trading within a historically significant support range of $133.85 to $147.95, where it has attracted strong buying interest on three separate occasions over the last decade [5] - Following previous rebounds from this support range, MOH stock has generated an average peak return of 75.7% [5] Cash Flow Metrics - The company has reported a nearly -1.3% free cash flow margin and a 3.0% operating margin for the last twelve months [6]